Lilla Nagy1
Karen Uray
Attila Tóth
Péter Bai- 1Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
- 2Department of Cardiology and Heart Surgery, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
- 3Section of Clinical Physiology, Department of Cardiology and Heart Surgery, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
- 4HAS-UD Vascular Biology and Myocardial Pathophysiology Research Group, Hungarian Academy of Sciences, Budapest, Hungary
- 5Research Center for Molecular Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
- 6MTA-DE Lendület Laboratory of Cellular Metabolism, Debrecen, Hungary
- 7MTA-DE Cell Biology and Signaling Research Group ELKH, Debrecen, Hungary
Beige adipocytes play key roles in organismal energy and metabolic balance. In this study, we assessed whether the supplementation of human white adipocytes, differentiated from human adipose tissue-derived stem cells, with nicotinamide riboside (NR), a potent NAD + precursor, can shift differentiation to beige adipocytes (beiging). NR induced mitochondrial biogenesis and the expression of beige markers (TBX1 and UCP1) in white adipocytes demonstrating that NR can declutch beiging. NR did not induce PARP activity but supported SIRT1 induction, which plays a key role in beiging. NR induced etomoxir-resistant respiration, suggesting increases in the oxidation of carbohydrates, carbohydrate breakdown products, or amino acids. Furthermore, NR boosted oligomycin-resistant respiration corresponding to uncoupled respiration. Enhanced etomoxir and oligomycin-resistant respiration were dependent on mitochondrial reactive-species production. Taken together, NR supplementation can induce beiging and uncoupled respiration, which are beneficial for combatting metabolic diseases.
1 Introduction
Altered organismal energy homeostasis contributes to the induction of metabolic diseases, such as obesity (Hall et al., 2022). Adipocytes play a major role in organismal energy homeostasis by storing or oxidizing fatty acids (Giordano et al., 2014; Cohen and Spiegelman, 2016). Both brown and beige adipocytes have considerable oxidative phosphorylation (OXPHOS) capacity (Wu et al., 2012). White adipocytes are responsible for lipid storage and lipid clearance from the circulation. Uncoupling between the OXPHOS and ATP production yields heat in brown and beige cells due to the overexpression of uncoupling protein-1 (UCP1). Brown cells have multiple lipid droplets in the cytoplasm and are often called multilocular adipocytes. Brown cells enshroud major arteries in adults, and newborns have extra brown cell-rich adipose tissue localized in the interscapular region (Lidell et al., 2013; Nedergaard and Cannon, 2018). Unstimulated, resting beige adipocytes can be found in regular adipose tissues and have similar unilocular morphology as white adipocytes (Altshuler-Keylin et al., 2016). Without stimulation the expression of thermogenic genes is low in beige cells (Petrovic et al., 2010; Waldén et al., 2012; Shabalina et al., 2013). Beige cells induce mitochondrial biogenesis in response to adrenergic stimulus and are very efficient in fatty acid oxidation (Wu et al., 2012; Harms and Seale, 2013). Beige adipocyte dysfunction is a serious risk factor for developing obesity and type II diabetes (Claussnitzer et al., 2015; Alcala et al., 2019; Scherer, 2019).
NAD+ is a central molecule in biochemistry that is often referred to as the NAD + -node. NAD + has a redox cycle (NAD+ ↔ NADH) and a non-redox cycle in which NAD+ is cleaved into nicotinamide (NA) and ADP-ribose (ADPR) and then resynthesized (NAD+ ↔ NA + ADPR) (Houtkooper et al., 2010). NAD+ is cleaved by sirtuins (SIRTs), PARPs, and CD38, while the resynthesis involves members of the enzyme machinery of NAD + salvage (Houtkooper et al., 2010; Nikiforov et al., 2011; Cantó et al., 2013). Increases in NAD + levels induce pathways that upregulate mitochondrial biogenesis and, consequently, alleviate insulin resistance and obesity (Houtkooper et al., 2010; Nikiforov et al., 2011; Cantó et al., 2013). NAD + precursors can efficiently boost NAD + levels (Canto et al., 2012; Giroud-Gerbetant et al., 2019). NAD + metabolism is linked to adipocyte differentiation (Luo et al., 2017; Ryu et al., 2018; Huang et al., 2020; Szanto and Bai, 2020; Szanto et al., 2021)
Nicotinamide-riboside (NR) is an NAD + precursor that efficiently induces cellular NAD + levels and mitochondrial biogenesis (Canto et al., 2012). NR supplementation efficiently induced mitochondrial biogenesis in models of obesity (Canto et al., 2012; Jukarainen et al., 2016; Rappou et al., 2016; Jokinen et al., 2017; Asnani-Kishnani et al., 2019; Vannini et al., 2019; Nascimento et al., 2021), inflammatory diseases (Wu et al., 2022), Parkinson’s (Brakedal et al., 2022), non-alcoholic fatty liver disease (Dall et al., 2021), and aging (Sun et al., 2021). The objective of this study was to assess the effects of NR on the induction of shift of differentiation of white adipocytes to beige adipocytes (beiging) in a human adipose tissue-derived mesenchymal stem cell (hADMSC) model.
2 Materials and methods
2.1 Chemicals
Chemicals were purchased from Sigma-Aldrich (St. Louis, MO, United States) unless stated otherwise. NR was a generous gift from ChromaDex (Los Angeles, CA, United States). NR concentration was selected based on literature search [e.g., (Canto et al., 2012; Ryu et al., 2016)]. Mito-TEMPO, a mitochondrial antioxidant (Jankó et al., 2021; Kacsir et al., 2021) was from Sigma-Aldrich (St. Louis, MO, United States).
2.2 Ethical statement
The study protocol was approved by the Ethics Committee of the University of Debrecen (Hungary) and the National Medical Research Council Committee of Human Reproduction (ETT TUKEB). All experiments were carried out in accordance with the Declaration of Helsinki and the approved ethical guidelines and regulations. Written informed consent was obtained from all participants before the surgical procedure.
2.3 Isolation, culture, and differentiation of hADMSCs
Human ADMSCs, also called stromal-vascular fraction (SVF) cells, were isolated from pericardial adipose tissue specimens as described in (Kristof et al., 2015; Abdul-Rahman et al., 2016). The hADMSCs were maintained and differentiated to white or beige adipocytes as described in (Nagy et al., 2019). Primary human adipose tissue-derived stem cells (hADMSC) were cultured in DMEM F-12 HAM containing 10% FBS, 1% penicillin/streptomycin, 33 µM Biotion and 17 µM Pantothenic acid. Before the induction of differentiation cells were grown to confluency then the following media were applied. For the differentiation of white adipocytes during the 1st–3rd days of differentiation serum-free DMEM HAM-F12 supplemented with 1% Penicilline- streptomycin, 33 µM Biotin, 17 µM Pantothenic acid, 10 μg/ml Apotransferrin, 200 p.m. 3,3′,5-Triiodo-L-thyronine sodium salt, 20 nM Human Insulin, 100 nM Hydrocortisone, 2 µM Rosiglitazone, 25 nM Dexamethasone, 500 µM 3-Isobutyl-1-methylxanthine that is exchanged for serum-free DMEM HAM-F12 supplemented with 1% Penicilline- streptomycin, 33 µM Biotin, 17 µM Pantothenic acid, 10 μg/ml Apotransferrin, 200 p.m. 3,3′,5-Triiodo-L-thyronine sodium salt, 20 nM Human Insulin, 100 nM Hydrocortisone between the 4th–14th day of differentiation. For the induction of the differentiation of beige adipocytes serum-free DMEM HAM-F12 supplemented with 1% Penicilline- streptomycin, 33 µM Biotin, 17 µM Pantothenic acid, 10 μg/ml Apotransferrin, 200 p.m. 3,3′,5-Triiodo-L-thyronine sodium salt, 850 nM Human Insulin, 1 µM Dexamethasone, 500 µM 3-Isobutyl-1-methylxanthine was used. From day 4th to day 14 serum-free DMEM HAM-F12 supplemented with 1% Penicilline- streptomycin, 33 µM Biotin, 17 µM Pantothenic acid, 10 μg/ml Apotransferrin, 200 p.m. 3,3’,5-Triiodo-L-thyronine sodium salt, 850 nM Human Insulin and 500 nM Rosiglitazone was applied. Medium was changed every 2 days. A subset of white adipocytes was treated with 500 µM NR for 14 days during the differentiation process.
2.4 Immunofluorescence and confocal microscopy
Mitochondrial structure was determined by staining differentiated hADMSCs with TOMM20 immunohistochemistry similar to (Jankó et al., 2021). The hADMSCs were seeded on glass coverslips and differentiated as described in 2.3. To detect TOMM20, differentiated cells were washed with PBS, fixed with 4% paraformaldehyde for 10 min at 37°C, and permeabilized with 1% Triton X-100 in PBS for 10 min. Between each step, cells were rinsed twice with PBS. Cells were blocked with 1% bovine serum albumin (BSA) in PBS for 1 h at room temperature. TOMM20 primary antibody was applied overnight (4°C, humidified chamber, diluted in blocking buffer). The next day, cells were washed and probed with Alexa Fluor 647-conjugated secondary antibody (Goat anti-Mouse IgG (H + L), Thermo Fisher Scientific, Waltham, MA, United States; excitation: 651 nm, emission: 667 nm). The pictures were taken with the ×40 objective of the system. Cell nuclei were visualized with DAPI (NucBlue Fixed Cell ReadyProbes Reagent, Thermo Fisher Scientific, Waltham, MA, United States). Confocal images were acquired with a Leica TCS SP8 confocal microscope (Leica, Wetzlar, Germany) and LAS X 3.5.5.19976 software (Leica, Wetzlar, Germany). Nonspecific binding of secondary antibodies was checked in control experiments (not shown). Processed images were analyzed using the ImageJ software Mito-Morphology Macro (Dagda et al., 2009; Dagda, 2019). Mitochondrial content, perimeter, circularity, and form factor were calculated from confocal microscopic images.
2.5 Gene expression and RT-qPCR
Reverse transcription-coupled real-time quantitative PCR (RT-qPCR) reactions were performed as described in (Bai et al., 2007). Primers are summarized in Table 1. Expression was normalized to the geometric mean of β-actin and 36B4 genes and was expressed as fold change.
TABLE 1. Human primers used in RT-qPCR reactions.
2.6 Protein extraction and western blotting
The hADMSCs were seeded, differentiated, and treated in 10 cm Petri dishes. Cell were rinsed with PBS 2 times, scraped, centrifuged, and lysed in RIPA lysis buffer (50 mM Tris, 150 mM NaCl, 0.1% SDS, 1% Triton X 100, 0.5% sodium deoxycholate, 1 mM EDTA, 1 mM Na3VO4, 1 mM NaF, and protease inhibitor cocktail). Western blotting was performed as described by (Nagy et al., 2018). Blots were probed with the antibodies summarized in Table 2. Signals were detected using enhanced chemiluminescence (ECL) and were captured by ChemiDoc Touch (Bio-Rad Laboratories, CA, United States).
TABLE 2. Primary antibodies used in the study.
2.7 Determination of differentiation rate
The rate of differentiation was determined as described in (Bai et al., 2007). The hADMSC cells were seeded, differentiated, and treated in 24-well plates. On the day of the experiment, cells were stained with Nile Red dye (10 μg/ml) in medium and incubated for 30 min at 37°C. Cells were rinsed with PBS 3 times, digested with Trypsin-EDTA, suspended in PBS, and pipetted in FACS tubes. The differentiation rate was determined using a NovoCyte Flow Cytometer (NovoCyte 3000, Acea Biosciences Inc., San Diego, United States) and analyzed using NovoExpress 1.2.5 Software. Differentiation rate was expressed as a percent of all cells.
2.8 Determination of oxygen consumption
Oxygen consumption rate (OCR) was determined using an XF96 Flux Analyzer using the assay plates designed for the instrument (Agilent Technologies, CA, United States). The hADMSCs were seeded in 96-well assay plates, then differentiated as described above. After recording the baseline oxygen consumption, cells were treated with a single bolus dose of dibutyril-cAMP (500 μM final concentration) to simulate adrenergic stimulation and OCR was recorded in 30 min intervals 5 times. Next, etomoxir (50 μM final concentration) was applied and OCR was recorded every 5 times for 3 min. Etomoxir is an inhibitor of mitochondrial fatty acid import (Declercq et al., 1987), etomoxir-sensitive respiration corresponds to fatty acid oxidation, while etomoxir-resistant respiration corresponds to the oxidation of other, non-fatty acid substrates. The cells were then treated with oligomycin (2.5 μM final concentration), and OCR was recorded every 5 times for 3 min. Oligomycin blocks the F1/F0 ATP synthase. Therefore, etomoxir-resistant respiration corresponds to uncoupled respiration. Finally, cells were treated with a single bolus dose of antimycin A (10 μM) and rotenone (5 μM) and OCR was recorded every 5 times for 3 min. These drugs completely block mitochondrial respiration and can be used to determine the baseline fluorescence intensity (i.e., background). After the measurement, XF96 cell plates were stained with Nile Red dye, and cell number and differentiation rate were determined using a Novocyte Flow cytometer (NovoCyte 3000, Acea Biosciences Inc., San Diego, United States) and analyzed using NovoExpress 1.2.5 Software. OCR values were normalized to the differentiation rate for each well and normalized readings were analyzed and plotted. The calculation and measurement procedure are published in (Miko et al., 2017).
2.9 Immunoprecipitation
Cells were lysed in RIPA lysis buffer as described in 2.6. PGC1α acetylation levels were analyzed by immunoprecipitating lysates with anti-PGC1α antibodies followed by Western blotting using an acetyl-lysine antibody and normalization to total PGC1α levels similar to (Bai et al., 2011a; Bai et al., 2011b).
2.10 Statistical analysis
Data were analyzed using GraphPad Prism nine software. The modified Thompson Tau test was used to identify outlier data points that were removed from the analysis. Normality was tested using D’Agonstino and Pearson tests. Statistical tests are stated in the figure legends. All data is represented as average ±SD, unless stated otherwise. All experiments were repeated at least three times.
3 Results
3.1 NR treatment induces mitochondrial biogenesis and mitochondrial oxidation in human primary white adipocytes
First, we measured mitochondrial content by immunofluorescently labeling TOMM20, a mitochondrial marker protein, followed by image analysis. Mitochondrial content was higher in beige cells compared with white adipocytes, similar to NR-treated white adipocytes (Figure 1A). Furthermore, beige and NR-treated adipocytes had a more fused mitochondrial network compared with the network of white adipocytes, marked by increases in the form factor (Figure 1A). These changes resulted in increases in mitochondrial oxidative activity upon cAMP stimulation. (Figure 1B). Furthermore, the substrates for mitochondrial oxidation were altered. In beige adipocytes, etomoxir-resistant respiration, representing carbohydrate and amino acid oxidation, decreased, while etomoxir-sensitive respiration, representing fatty acid oxidation, increased (Figure 1B) compared with respiration in white adipocytes. In NR-treated cells, etomoxir-resistant respiration was similar to white adipocytes, while, fatty acid oxidation was higher in beige adipocytes (Figure 1B), highlighting the robust increases in fatty acid oxidation in response to NR treatment. Oligomycin-resistant respiration, a proxy for uncoupled respiration, increased in beige adipocytes compared with white and beige cells (Figure 1B). Furthermore, oligomycin-sensitive respiration, representing coupled-respiration, increased both in beige and NR-treated cells (Figure 1B).
FIGURE 1. NR-treatment shifts the differentiation of white adipocytes to beige-like cells. The hADMSCs cells from three donors were seeded and differentiated to mature adipocytes. Cells were treated with NR (500 µM) throughout the differentiation process. (A) Differentiated cells were stained with TOMM20 antibody, then mitochondrial quantity and morphology were evaluated (B) Human adipose tissue-derived mesenchymal stem cells were seeded into Seahorse assay plates and assayed after differentiation. Mitochondrial oxygen consumption was assessed as described in Materials and Methods. (C) Adipocyte differentiation rate was determined as described in Materials and Methods (D) The expression levels of the indicated genes were measured by RT-qPCR in differentiated human adipose tissue-derived mesenchymal stem cells. (E) UCP1 protein expression was measured by Western blot in differentiated human adipose tissue-derived mesenchymal stem cells (F) The expression levels of the indicated genes were measured by RT-qPCR in differentiated human adipose tissue-derived mesenchymal stem cells. Normality was checked. Statistical significance was assessed by One-way ANOVA test followed by a post-hoc test versus white adipocytes. *, **, *** indicate significant differences between groups at p < 0.05, p < 0.01 or p < 0.001, respectively. Data are represented as means ± SD. Data are expressed as fold change normalized to white adipocytes. Abbreviations: ETO-S, etomoxir sensitive; ETO-R, etomoxir-resistant; hADMSC, human adipose tissue-derived mesenchymal stem cell; NR, nicotinamide-riboside; PAR, poly (ADP-ribose); UCP, uncoupling protein-1.
NR treatment reduced the rate of differentiation in adipocytes compared with white adipocytes (Figure 1C), similar to treatment of cells with olaparib, a PARP inhibitor (Nagy et al., 2019). The mRNA and protein expression levels of a brown and beige marker gene, uncoupling protein-1 (UCP1), which drives uncoupled respiration and heat generation (Cinti, 2017), and T-Box Transcription Factor (TBX1), a beige-specific marker. The mRNA expression levels of UCP1 and TBX1 were higher in beige and NR-treated cells compared with white adipocytes (Figure 1D). Furthermore, higher UCP1 mRNA expression was translated to higher UCP1 protein levels in beige and NR-treated cells (Figure 1E). Finally, we assessed the mRNA expression of adipogenic marker genes. The expression of peroxisome proliferator activated receptor- γ1 (PPARγ1), fatty acid binding protein-4 (FABP4), fatty acid synthase (FAS), perilipin, and tumor necrosis factor α (TNFα) increased, while lipoprotein lipase (LPL) decreased in beige adipocytes compared with expression levels in white adipocytes (Figure 1F). NR-treatment of white adipocytes did not elicit identical changes to gene expression as beige differentiation. NR treatment induced the expression of perilipin and decreased the expression of LPL and FABP4 but did not alter the expression of PPARγ, FAS, and TNFα, suggesting that NR-treated cells have a different adipogenic enzyme composition and, therefore, different function.
3.2 NR treatment induces SIRT1 activation but not excess PARP1 activation
NR is a precursor of NAD + salvage and can support the activity of NAD + -dependent enzymes, such as PARPs or sirtuins (Canto et al., 2012). First, we assessed the mRNA expression of PARP enzymes known to be involved in regulating mitochondrial metabolism, including PARP1 (Virag et al., 1998; Bai et al., 2011b), PARP2 (Bai et al., 2011a; Mohamed et al., 2014), PARP3 (Rodriguez-Vargas et al., 2020), PARP5a (TNKS1), PARP5b (TNKS2) (Yeh et al., 2009; Wang et al., 2020), and PARP10 (Marton et al., 2018). The activity of PARP1 and PARP2, the enzymes responsible for the bulk of cellular PARP activity (Schreiber et al., 2002; Szanto et al., 2011), and PARP10 did not change in response to NR supplementation (Figure 2A). However, the mRNA levels of PARP3, PARP5a, and PARP5b were slightly increased by NR (Figure 2A). Of note, the mRNA expression levels of PARP3, PARP5a, and PARP5b were also elevated upon differentiation of hADMSCs into beige adipocytes (Figure 2A). These findings prompted us to assess poly- and mono-ADP-ribosylation in cells. No differences in cellular levels of poly-ADP-ribose or mono-ADP-ribose were detected (Figure 2B), suggesting that NR supplementation did not induce PARP activity.
FIGURE 2. NR supplementation does not induce PARP activity but induces SIRT1 in hADMSC-derived adipocytes. Human adipose tissue-derived mesenchymal stem cells from three different controls were differentiated to adipocytes as described in Materials and Methods. (A) The expression levels of the indicated genes were determined using RT-qPCR (B) Poly (ADP-ribose) and mono-ADP-ribose levels were determined by Western blot. (C) PGC-1α was immunoprecipitated and acetylation levels were determined in the immunprecipitates. Normality was checked. Statistical significance was assessed by One-way ANOVA test followed by a post-hoc test versus white adipocytes. *, **, *** indicate significant differences between groups at p < 0.05, p < 0.01 or p < 0.001, respectively. Data are represented as means ± SD. Data are expressed as fold change normalized to white adipocytes. Abbreviations: hADMSC, human adipose tissue-derived mesenchymal stem cell; NR, nicotinamide-riboside; PAR, poly (ADP-ribose); PGC1α, peroxisome proliferator-activated receptor gamma coactivator-1α.
Sirtuins are also major NAD + consumers in cells and SIRT1 is a major driver of beige differentiation (Fu et al., 2014; Khanh et al., 2018; Liao et al., 2021). Therefore, we assessed SIRT1 activity in differentiated cells. Peroxisome proliferator-activated receptor gamma coactivator-1α (PGC1α) is a target of SIRT1 deacetylation (Nemoto et al., 2005). Hence, determining changes in PGC1α acetylation is a good proxy for SIRT1 activity. In addition, PGC1α is a key element in beige differentiation (Yan et al., 2016). PGC1α acetylation levels decreased in beige cells compared with white adipocytes, similar to NR-treated cells (Figure 2C), suggesting the SIRT1 activity increased during beige differentiation and upon NR-induced shift in differentiation.
3.3 NR treatment supports uncoupled respiration through mitochondrial reactive species production
Mitochondrial reactive species play a fundamental role in inducing mitochondrial biogenesis (Valero, 2014; Fu et al., 2018; Ryoo and Kwak, 2018; Palmeira et al., 2019; Jankó et al., 2021). We tested whether reactive species were produced in our system by supplementing the differentiation medium with Mito-TEMPO, a mitochondrial-targeted antioxidant, during the differentiation process. Mito-TEMPO treatment did not influence baseline, cAMP-induced, or etomoxir-sensitive (representing fatty acid oxidation) mitochondrial oxidation rates (Figure 3A). However, etomoxir-resistant rates (representing amino acid and carbohydrate oxidation) were increased in response to Mito-TEMPO treatment in white and beige adipocytes, suggesting that reactive species production is important in driving fatty acid oxidation (Figure 3A). A similar trend was observed in NR-treated cells; however, the changes were not statistically significant (Figure 3A). No differences in the oligomycin-sensitive fraction of mitochondrial oxidation, corresponding to coupled-respiration, were detected. Nevertheless, Mito-TEMPO suppressed oligomycin-resistant (uncoupled) respiration in white and beige adipocytes and NR-treated white adipocytes (Figure 3A). These results highlight the key role of reactive species production in uncoupling. Mito-TEMPO treatment did not influence mitochondrial morphology (Figure 3B).
FIGURE 3. Mitochondria-derived reactive species production supports a switch towards uncoupled respiration. (A) Human adipose tissue-derived mesenchymal stem cells from three different donors were seeded in Seahorse plates and differentiated to adipocytes and mitochondrial oxidation was determined as described in Materials and Methods. The bottom graph depicts the same data on a log2-scale for better visibility (B) Human adipose tissue-derived mesenchymal stem cells from three different donors were seeded on coverslips, differentiated, stained with a TOMM20 antibody, and mitochondrial morphology was assessed as described in Materials and Methods. The bar equals to 25 µm. Normality was checked. Statistical significance was assessed by Two-way ANOVA test followed by a post-hoc test that compares all possible combinations. * and ** symbolize significant differences between groups at p < 0.05 or p < 0.01, respectively. Data are represented as means ± SD. Data are expressed as fold change, where white adipocytes were considered as 1. Abbreviations: ETO-S, etomoxir sensitive; ETO-R, etomoxir-resistant; hADMSC, human adipose tissue-derived mesenchymal stem cell; Mito, mitochondria; MT, Mito-TEMPO; NR, nicotinamide-riboside; Oligo-S, oligomycin sensitive; Oligo-R, oligomycin resistant.
4 Discussion
In this study, we assessed the applicability of an NAD + precursor, NR, in shifting the differentiation of human adipose-derived pluripotent cells differentiated to white adipocytes. NR supplementation induced mitochondrial biogenesis and, consequently, increased mitochondrial oxidative capacity. These changes coincided with increased expression of UCP1, a marker of uncoupled mitochondrial oxidation, and TBX1, a beige marker gene. NR suppressed the rate of differentiation, similar to olaparib, a PARP inhibitor that induces NAD + -sparing and declutches beige transdifferentiation in the same model system (Nagy et al., 2019).
Previous studies identified NAD + as a key player in the induction of thermogenesis (Yamaguchi et al., 2019) and NR supplementation induces NAD + levels (Canto et al., 2012). NAD + interacts with a plethora of enzymes (Ziegler, 2000; Houtkooper et al., 2010; Nikiforov et al., 2011; Chiarugi et al., 2012; Bai et al., 2015), some of which are involved in intermediary metabolism and higher order metabolic regulation in beige or brown adipose tissue differentiation and function. These enzymes include AMP-activated protein kinase (AMPK) (Shan et al., 2013; Abdul-Rahman et al., 2016; Mottillo et al., 2016; Zhu et al., 2016; Desjardins and Steinberg, 2018; Imran et al., 2018; Wu et al., 2018; Serrano et al., 2020), PGC1α (Shan et al., 2013; Nagy et al., 2019), and SIRT1 (Qiang et al., 2012; Khanh et al., 2018; Asnani-Kishnani et al., 2019). Serrano and colleagues showed that NR also induces epigenetic changes (Serrano et al., 2020). We observed the activation of SIRT1 in response to NR treatment, which is consistent with previous studies (Qiang et al., 2012; Khanh et al., 2018). PARP enzymes are major consumers of NAD+ and can degrade NAD+ and limit NAD + availability to sirtuins (Bai et al., 2011a; Bai et al., 2011b; Cantó et al., 2013). However, we did not detect PARP activation in response to NR supplementation, suggesting that increases in NAD + support SIRT1 but not activation of PARP enzymes.
We observed changes in substrate preferences in NR-treated cells that were dependent on mitochondria-derived reactive species. Mito-TEMPO, a mitochondrial reactive species scavenger, induced etomoxir-resistant respiration in adipocytes but did not affect etomoxir-sensitive respiration (Figure 3A). Etomoxir is an inhibitor of mitochondrial fatty acid import (Declercq et al., 1987). Hence, etomoxir-sensitive respiration corresponds to fatty acid oxidation, while etomoxir-resistant respiration corresponds to the oxidation of carbohydrates, carbohydrate degradation products (e.g., pyruvate), and other substrates (e.g., amino acids). Thus, our data suggest that increased mitochondrial oxidation upon cAMP stimulation is dependent on increased carbohydrate and amino acid oxidation. Our observations are consistent with Dall et al. (Dall et al., 2019), who showed that the beneficial effects of NR treatment in liver mitochondria were dependent on glutamine and pyruvate oxidation. Pyruvate oxidation was implicated in modulating obesity and adipose tissue function (Ingram and Roth, 2021). However, our findings conflict with the findings of Canto et al. (Canto et al., 2012), who reported increases in fatty acid oxidation in NR-treated C57/Bl6 mice. Shi et al. (Shi et al., 2017) reported that NR administration to mice supported metabolic flexibility marked by large changes in respiratory quotient (or respiratory exchange ratio) values between the fed and fasted states compared with vehicle-fed animals.
Another important finding of this study is the key role that mitochondria-derived reactive species play in setting the ratio of coupled to uncoupled respiration. Mito-TEMPO treatment decreased the oligomycin-resistant fraction of respiration, indicating decreased uncoupled respiration in white, beige, and NR-treated adipocytes, while Mito-TEMPO had no effect on oligomycin-sensitive, coupled respiration. In other words, mitochondrial reactive species production is needed to support uncoupled respiration. Consistent with this conclusion, Chouchani and colleagues showed that the addition of the general thiol reductant, N-acetyl-cysteine (NAC), reduced UCP1-mediated uncoupling in mitochondria (Chouchani et al., 2016). NAC is a general thiol reducing agent and may affect thiols and redox-labile groups outside the mitochondria. Mito-TEMPO is specific for the mitochondria. Hence, our results consolidate the role of mitochondrial reactive species production in inducing uncoupled respiration. In addition, these data highlight the role of reactive species in regulating mitochondrial oxidation. The accepted view is that reactive species inhibit mitochondrial respiration by oxidizing components of the electron transport chain (Wang et al., 2010). Our results indicate that reactive species overproduction can induce uncoupling that spares destructive oxidation of mitochondrial oxidative phosphorylation machinery. Nevertheless, in human subjects, NR had no impact on thermogenesis (Nascimento et al., 2021), leaving the question open about how these findings can be translated to humans.
In this study, we showed that the application of NR to hADMSCs shifted the differentiation of white adipocytes to beige. Furthermore, we showed that SIRT1 induction and reactive species production play key roles in differentiation, mitochondrial biogenesis, substrate preference, and the induction of uncoupled respiration. These results have implications for understanding organismal energy balance mechanisms and may have implications in the metabolic arena.
Data availability statement
The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: https://figshare.com/s/b553ecd08aca5c0b1347.
Ethics statement
The studies involving human participants were reviewed and approved by the Ethics Committee of the University of Debrecen (Hungary) and the National Medical Research Council Committee of Human Reproduction (ETT TUKEB). The patients/participants provided their written informed consent to participate in this study.
Author contributions
LN and BR performed experiments; TS and AT supplied human samples; PB, KU, and AT conceptualized and supervised research, wrote the paper, and contributed to the manuscript editing.
Funding
The work was supported by grants from the NKFIH (K123975, K142141, TKP2021-EGA-19, TKP2021-EGA-20). The Project nos. TKP2021-EGA-19 and TKP2021-EGA-20, K132623 were implemented with the support provided by the National Research, Development and Innovation Fund of Hungary, financed under the TKP2021-EGA funding scheme. The POST-COVID2021-33 grant to PB was from the Hungarian Academy of Sciences. The research was financed by the Thematic Excellence Program of the Ministry for Innovation and Technology in Hungary (TKP2020-IKA-04, TKP2020-NKA-04).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. ChromaDex had no impact on the study design and interpretation.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
Abdul-Rahman, O., Kristof, E., Doan-Xuan, Q. M., Vida, A., Nagy, L., Horvath, A., et al. (2016). AMP-activated kinase (AMPK) activation by AICAR in human white adipocytes derived from pericardial white adipose tissue stem cells induces a partial beige-like phenotype. PLoS One 11 (6), e0157644. doi:10.1371/journal.pone.0157644
Alcala, M., Calderon-Dominguez, M., Serra, D., Herrero, L., and Viana, M. (2019). Mechanisms of impaired Brown adipose tissue recruitment in obesity. Front. Physiol. 10, 94. doi:10.3389/fphys.2019.00094
Altshuler-Keylin, S., Shinoda, K., Hasegawa, Y., Ikeda, K., Hong, H., Kang, Q., et al. (2016). Beige adipocyte maintenance is regulated by autophagy-induced mitochondrial clearance. Cell Metab. 24 (3), 402–419. doi:10.1016/j.cmet.2016.08.002
Asnani-Kishnani, M., Rodriguez, A. M., Serrano, A., Palou, A., Bonet, M. L., and Ribot, J. (2019). Neonatal resveratrol and nicotinamide riboside supplementations sex-dependently affect beige transcriptional programming of preadipocytes in mouse adipose tissue. Front. Physiol. 10, 83. doi:10.3389/fphys.2019.00083
Bai, P., Canto, C., Brunyánszki, A., Huber, A., Szántó, M., Cen, Y., et al. (2011a). PARP-2 regulates SIRT1 expression and whole-body energy expenditure. Cell Metab. 13 (4), 450–460. doi:10.1016/j.cmet.2011.03.013
Bai, P., Cantó, C., Oudart, H., Brunyánszki, A., Cen, Y., Thomas, C., et al. (2011b). PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab. 13 (4), 461–468. doi:10.1016/j.cmet.2011.03.004
Bai, P., Houten, S. M., Huber, A., Schreiber, V., Watanabe, M., Kiss, B., et al. (2007). Poly(ADP-ribose) polymerase-2 [corrected] controls adipocyte differentiation and adipose tissue function through the regulation of the activity of the retinoid X receptor/peroxisome proliferator-activated receptor-gamma [corrected] heterodimer. J. Biol. Chem. 282 (52), 37738–37746. doi:10.1074/jbc.M701021200
Bai, P., Nagy, L., Fodor, T., Liaudet, L., and Pacher, P. (2015). Poly(ADP-ribose) polymerases as modulators of mitochondrial activity. Trends Endocrinol. Metab. 26 (2), 75–83. doi:10.1016/j.tem.2014.11.003
Brakedal, B., Dölle, C., Riemer, F., Ma, Y., Nido, G. S., Skeie, G. O., et al. (2022). The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. Cell Metab. 34 (3), 396–407.e6. e396. doi:10.1016/j.cmet.2022.02.001
Canto, C., Houtkooper, R. H., Pirinen, E., Youn, D. Y., Oosterveer, M. H., Cen, Y., et al. (2012). The NAD(+) precursor nicotinamide riboside Enhances oxidative metabolism and Protects against high-fat diet-induced obesity. Cell Metab. 15 (6), 838–847. doi:10.1016/j.cmet.2012.04.022
Cantó, C., Sauve, A., and Bai, P. (2013). Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes. Mol. Asp. Med. 34 (6), 1168–1201. doi:10.1016/j.mam.2013.01.004
Chiarugi, A., Dolle, C., Felici, R., and Ziegler, M. (2012). The NAD metabolome - a key determinant of cancer cell biology. Nat. Rev. Cancer 12 (11), 741–752. doi:10.1038/nrc3340
Chouchani, E. T., Kazak, L., Jedrychowski, M. P., Lu, G. Z., Erickson, B. K., Szpyt, J., et al. (2016). Mitochondrial ROS regulate thermogenic energy expenditure and sulfenylation of UCP1. Nature 532 (7597), 112–116. doi:10.1038/nature17399
Cinti, S. (2017). UCP1 protein: The molecular hub of adipose organ plasticity. Biochimie 134, 71–76. doi:10.1016/j.biochi.2016.09.008
Claussnitzer, M., Dankel, S. N., Kim, K. H., Quon, G., Meuleman, W., Haugen, C., et al. (2015). FTO obesity variant circuitry and adipocyte browning in humans. N. Engl. J. Med. 373 (10), 895–907. doi:10.1056/NEJMoa1502214
Cohen, P., and Spiegelman, B. M. (2016). Cell biology of fat storage. Mol. Biol. Cell 27 (16), 2523–2527. doi:10.1091/mbc.E15-10-0749
Dagda, R. K., Cherra, S. J., Kulich, S. M., Tandon, A., Park, D., and Chu, C. T. (2009). Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. J. Biol. Chem. 284 (20), 13843–13855. doi:10.1074/jbc.M808515200
Dagda, R. K. (2019). Mito-morphology macro [online]. Available at: https://imagejdocu.tudor.lu/plugin/morphology/mitochondrial_morphology_macro_plug-in/start (Accessed 06 24, 2020).
Dall, M., Hassing, A. S., Niu, L., Nielsen, T. S., Ingerslev, L. R., Sulek, K., et al. (2021). Hepatocyte-specific perturbation of NAD(+) biosynthetic pathways in mice induces reversible nonalcoholic steatohepatitis-like phenotypes. J. Biol. Chem. 297 (6), 101388. doi:10.1016/j.jbc.2021.101388
Dall, M., Trammell, S. A. J., Asping, M., Hassing, A. S., Agerholm, M., Vienberg, S. G., et al. (2019). Mitochondrial function in liver cells is resistant to perturbations in NAD(+) salvage capacity. J. Biol. Chem. 294 (36), 13304–13326. doi:10.1074/jbc.RA118.006756
Declercq, P. E., Falck, J. R., Kuwajima, M., Tyminski, H., Foster, D. W., and McGarry, J. D. (1987). Characterization of the mitochondrial carnitine palmitoyltransferase enzyme system. I. Use of inhibitors. J. Biol. Chem. 262 (20), 9812–9821. doi:10.1016/s0021-9258(18)48006-4
Desjardins, E. M., and Steinberg, G. R. (2018). Emerging role of AMPK in Brown and beige adipose tissue (BAT): Implications for obesity, insulin resistance, and type 2 diabetes. Curr. Diab. Rep. 18 (10), 80. doi:10.1007/s11892-018-1049-6
Fu, M. H., Wu, C. W., Lee, Y. C., Hung, C. Y., Chen, I. C., and Wu, K. L. H. (2018). Nrf2 activation attenuates the early suppression of mitochondrial respiration due to the alpha-synuclein overexpression. Biomed. J. 41 (3), 169–183. doi:10.1016/j.bj.2018.02.005
Fu, T., Seok, S., Choi, S., Huang, Z., Suino-Powell, K., Xu, H. E., et al. (2014). MicroRNA 34a inhibits beige and brown fat formation in obesity in part by suppressing adipocyte fibroblast growth factor 21 signaling and SIRT1 function. Mol. Cell. Biol. 34 (22), 4130–4142. doi:10.1128/MCB.00596-14
Giordano, A., Smorlesi, A., Frontini, A., Barbatelli, G., and Cinti, S. (2014). White, brown and pink adipocytes: the extraordinary plasticity of the adipose organ. Eur. J. Endocrinol. 170 (5), R159–R171. doi:10.1530/EJE-13-0945
Giroud-Gerbetant, J., Joffraud, M., Giner, M. P., Cercillieux, A., Bartova, S., Makarov, M. V., et al. (2019). A reduced form of nicotinamide riboside defines a new path for NAD(+) biosynthesis and acts as an orally bioavailable NAD(+) precursor. Mol. Metab. 30, 192–202. doi:10.1016/j.molmet.2019.09.013
Hall, K. D., Farooqi, I. S., Friedman, J. M., Klein, S., Loos, R. J. F., Mangelsdorf, D. J., et al. (2022). The energy balance model of obesity: beyond calories in, calories out. Am. J. Clin. Nutr. 115 (5), 1243–1254. doi:10.1093/ajcn/nqac031
Harms, M., and Seale, P. (2013). Brown and beige fat: development, function and therapeutic potential. Nat. Med. 19 (10), 1252–1263. doi:10.1038/nm.3361
Houtkooper, R. H., Canto, C., Wanders, R. J., and Auwerx, J. (2010). The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways. Endocr. Rev. 31 (2), 194–223. doi:10.1210/er.2009-0026
Huang, D., Camacho, C. V., Setlem, R., Ryu, K. W., Parameswaran, B., Gupta, R. K., et al. (2020). Functional interplay between histone H2B ADP-ribosylation and phosphorylation controls adipogenesis. Mol. Cell 79 (6), 934–949. doi:10.1016/j.molcel.2020.08.002
Imran, K. M., Yoon, D., and Kim, Y. S. (2018). A pivotal role of AMPK signaling in medicarpin-mediated formation of brown and beige. Biofactors 44 (2), 168–179. doi:10.1002/biof.1392
Ingram, D. K., and Roth, G. S. (2021). Glycolytic inhibition: an effective strategy for developing calorie restriction mimetics. GeroScience 43 (3), 1159–1169. doi:10.1007/s11357-020-00298-7
Jankó, L., Kovács, T., Laczik, M., Sári, Z., Ujlaki, G., Kis, G., et al. (2021). Silencing of poly(ADP-ribose) polymerase-2 induces mitochondrial reactive species production and mitochondrial fragmentation. Cells 10 (6), 1387. doi:10.3390/cells10061387
Jokinen, R., Pirnes-Karhu, S., Pietiläinen, K. H., and Pirinen, E. (2017). Adipose tissue NAD(+)-homeostasis, sirtuins and poly(ADP-ribose) polymerases -important players in mitochondrial metabolism and metabolic health. Redox Biol. 12, 246–263. doi:10.1016/j.redox.2017.02.011
Jukarainen, S., Heinonen, S., Ramo, J. T., Rinnankoski-Tuikka, R., Rappou, E., Tummers, M., et al. (2016). Obesity is associated with low NAD(+)/SIRT pathway expression in adipose tissue of BMI-discordant monozygotic twins. J. Clin. Endocrinol. Metab. 101 (1), 275–283. doi:10.1210/jc.2015-3095
Kacsir, I., Sipos, A., Ujlaki, G., Buglyo, P., Somsak, L., Bai, P., et al. (2021). Ruthenium half-sandwich type complexes with bidentate monosaccharide ligands show antineoplastic activity in ovarian cancer cell models through reactive oxygen species production. Int. J. Mol. Sci. 22 (19), 10454. doi:10.3390/ijms221910454
Khanh, V. C., Zulkifli, A. F., Tokunaga, C., Yamashita, T., Hiramatsu, Y., and Ohneda, O. (2018). Aging impairs beige adipocyte differentiation of mesenchymal stem cells via the reduced expression of Sirtuin 1. Biochem. Biophys. Res. Commun. 500 (3), 682–690. doi:10.1016/j.bbrc.2018.04.136
Kristof, E., Doan-Xuan, Q. M., Bai, P., Bacso, Z., and Fesus, L. (2015). Laser-scanning cytometry can quantify human adipocyte browning and proves effectiveness of irisin. Sci. Rep. 5, 12540. doi:10.1038/srep12540
Liao, Z. M., Li, A. N., Cai, Y., Chen, J. J., Xu, Y., Sui, L. H., et al. (2021). Skip participates in formation and lipid metabolism of beige adipose and might mediate the effects of SIRT1 activator BTM-0512 on beige remodeling. Biochem. Biophys. Res. Commun. 537, 109–117. doi:10.1016/j.bbrc.2020.12.058
Lidell, M. E., Betz, M. J., Dahlqvist Leinhard, O., Heglind, M., Elander, L., Slawik, M., et al. (2013). Evidence for two types of brown adipose tissue in humans. Nat. Med. 19 (5), 631–634. doi:10.1038/nm.3017
Luo, X., Ryu, K. W., Kim, D. S., Nandu, T., Medina, C. J., Gupte, R., et al. (2017). PARP-1 controls the adipogenic transcriptional Program by PARylating C/EBPβ and modulating its transcriptional activity. Mol. Cell 65 (2), 260–271. doi:10.1016/j.molcel.2016.11.015
Marton, J., Fodor, T., Nagy, L., Vida, A., Kis, G., Brunyanszki, A., et al. (2018). PARP10 (ARTD10) modulates mitochondrial function. PLoS One 13 (1), e0187789. doi:10.1371/journal.pone.0187789
Miko, E., Kovacs, T., Fodor, T., and Bai, P. (2017). Methods to assess the role of poly(ADP-ribose) polymerases in regulating mitochondrial oxidation. Methods Mol. Biol. 1608, 185–200. doi:10.1007/978-1-4939-6993-7_13
Mohamed, J. S., Hajira, A., Pardo, P. S., and Boriek, A. M. (2014). MicroRNA-149 inhibits PARP-2 and promotes mitochondrial biogenesis via SIRT-1/PGC-1α network in skeletal muscle. Diabetes 63 (5), 1546–1559. doi:10.2337/db13-1364
Mottillo, E. P., Desjardins, E. M., Crane, J. D., Smith, B. K., Green, A. E., Ducommun, S., et al. (2016). Lack of adipocyte AMPK exacerbates insulin resistance and hepatic steatosis through brown and beige adipose tissue function. Cell Metab. 24 (1), 118–129. doi:10.1016/j.cmet.2016.06.006
Nagy, L., Marton, J., Vida, A., Kis, G., Bokor, E., Kun, S., et al. (2018). Glycogen phosphorylase inhibition improves beta cell function. Br. J. Pharmacol. 175 (2), 301–319. doi:10.1111/bph.13819
Nagy, L., Rauch, B., Balla, N., Ujlaki, G., Kis, G., Abdul-Rahman, O., et al. (2019). Olaparib induces browning of in vitro cultures of human primary white adipocytes. Biochem. Pharmacol. 25 (19), 76–85. doi:10.1016/j.bcp.2019.06.022
Nascimento, E. B. M., Moonen, M. P. B., Remie, C. M. E., Gariani, K., Jörgensen, J. A., Schaart, G., et al. (2021). Nicotinamide riboside Enhances in vitro beta-adrenergic brown adipose tissue activity in humans. J. Clin. Endocrinol. Metab. 106 (5), 1437–1447. doi:10.1210/clinem/dgaa960
Nedergaard, J., and Cannon, B. (2018). Brown adipose tissue as a heat-producing thermoeffector. Handb. Clin. Neurol. 156, 137–152. doi:10.1016/B978-0-444-63912-7.00009-6
Nemoto, S., Fergusson, M. M., and Finkel, T. (2005). SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}. J. Biol. Chem. 280 (16), 16456–16460. doi:10.1074/jbc.M501485200
Nikiforov, A., Dolle, C., Niere, M., and Ziegler, M. (2011). Pathways and subcellular compartmentation of NAD biosynthesis in human cells: from entry of extracellular precursors to mitochondrial NAD generation. J. Biol. Chem. 286 (24), 21767–21778. doi:10.1074/jbc.M110.213298
Palmeira, C. M., Teodoro, J. S., Amorim, J. A., Steegborn, C., Sinclair, D. A., and Rolo, A. P. (2019). Mitohormesis and metabolic health: The interplay between ROS, cAMP and sirtuins. Free Radic. Biol. Med. 141, 483–491. doi:10.1016/j.freeradbiomed.2019.07.017
Petrovic, N., Walden, T. B., Shabalina, I. G., Timmons, J. A., Cannon, B., and Nedergaard, J. (2010). Chronic peroxisome proliferator-activated receptor gamma (PPARgamma) activation of epididymally derived white adipocyte cultures reveals a population of thermogenically competent, UCP1-containing adipocytes molecularly distinct from classic brown adipocytes*. J. Biol. Chem. 285 (10), 7153–7164. doi:10.1074/jbc.M109.053942
Qiang, L., Wang, L., Kon, N., Zhao, W., Lee, S., Zhang, Y., et al. (2012). Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Pparγ. Cell 150 (3), 620–632. doi:10.1016/j.cell.2012.06.027
Rappou, E., Jukarainen, S., Rinnankoski-Tuikka, R., Kaye, S., Heinonen, S., Hakkarainen, A., et al. (2016). Weight loss is associated with increased NAD(+)/SIRT1 expression but reduced PARP activity in white adipose tissue. J. Clin. Endocrinol. Metab. 101 (3), 1263–1273. doi:10.1210/jc.2015-3054
Rodriguez-Vargas, J. M., Martin-Hernandez, K., Wang, W., Kunath, N., Suganthan, R., Amé, J. C., et al. (2020). Parp3 promotes astrocytic differentiation through a tight regulation of Nox4-induced ROS and mTorc2 activation. Cell Death Dis. 11 (11), 954. doi:10.1038/s41419-020-03167-5
Ryoo, I. G., and Kwak, M. K. (2018). Regulatory crosstalk between the oxidative stress-related transcription factor Nfe2l2/Nrf2 and mitochondria. Toxicol. Appl. Pharmacol. 359, 24–33. doi:10.1016/j.taap.2018.09.014
Ryu, D., Zhang, H., Ropelle, E. R., Sorrentino, V., Mázala, D. A., Mouchiroud, L., et al. (2016). NAD+ repletion improves muscle function in muscular dystrophy and counters global PARylation. Sci. Transl. Med. 8 (361), 361ra139. doi:10.1126/scitranslmed.aaf5504
Ryu, K. W., Nandu, T., Kim, J., Challa, S., DeBerardinis, R. J., and Kraus, W. L. (2018). Metabolic regulation of transcription through compartmentalized NAD(+) biosynthesis. Science 360 (6389), eaan5780. doi:10.1126/science.aan5780
Scherer, P. E. (2019). The many secret lives of adipocytes: implications for diabetes. Diabetologia 62 (2), 223–232. doi:10.1007/s00125-018-4777-x
Schreiber, V., Ame, J. C., Dolle, P., Schultz, I., Rinaldi, B., Fraulob, V., et al. (2002). Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient base excision DNA repair in association with PARP-1 and XRCC1. J. Biol. Chem. 277 (25), 23028–23036. doi:10.1074/jbc.M202390200
Serrano, A., Asnani-Kishnani, M., Couturier, C., Astier, J., Palou, A., Landrier, J.-F., et al. (2020). DNA methylation changes are associated with the programming of white adipose tissue browning features by resveratrol and nicotinamide riboside neonatal supplementations in mice. Nutrients 12 (2), 461. doi:10.3390/nu12020461
Shabalina, I. G., Petrovic, N., de Jong, J. M., Kalinovich, A. V., Cannon, B., and Nedergaard, J. (2013). UCP1 in brite/beige adipose tissue mitochondria is functionally thermogenic. Cell Rep. 5 (5), 1196–1203. doi:10.1016/j.celrep.2013.10.044
Shan, T., Liang, X., Bi, P., and Kuang, S. (2013). Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1α-Fndc5 pathway in muscle. FASEB J. 27 (5), 1981–1989. doi:10.1096/fj.12-225755
Shi, W., Hegeman, M. A., van Dartel, D. A. M., Tang, J., Suarez, M., Swarts, H., et al. (2017). Effects of a wide range of dietary nicotinamide riboside (NR) concentrations on metabolic flexibility and white adipose tissue (WAT) of mice fed a mildly obesogenic diet. Mol. Nutr. Food Res. 61 (8), 1600878. doi:10.1002/mnfr.201600878
Sun, X., Cao, B., Naval-Sanchez, M., Pham, T., Sun, Y. B. Y., Williams, B., et al. (2021). Nicotinamide riboside attenuates age-associated metabolic and functional changes in hematopoietic stem cells. Nat. Commun. 12 (1), 2665. doi:10.1038/s41467-021-22863-0
Szanto, M., and Bai, P. (2020). The role of ADP-ribose metabolism in metabolic regulation, adipose tissue differentiation, and metabolism. Genes. Dev. 34 (5-6), 321–340. doi:10.1101/gad.334284.119
Szanto, M., Gupte, R., Kraus, W. L., Pacher, P., and Bai, P. (2021). PARPs in lipid metabolism and related diseases. Prog. Lipid Res. 84, 101117. doi:10.1016/j.plipres.2021.101117
Szanto, M., Rutkai, I., Hegedus, C., Czikora, A., Rozsahegyi, M., Kiss, B., et al. (2011). Poly(ADP-ribose) polymerase-2 depletion reduces doxorubicin-induced damage through SIRT1 induction. Cardiovasc. Res. 92 (3), 430–438. doi:10.1093/cvr/cvr246
Valero, T. (2014). Mitochondrial biogenesis: pharmacological approaches. Curr. Pharm. Des. 20 (35), 5507–5509. doi:10.2174/138161282035140911142118
Vannini, N., Campos, V., Girotra, M., Trachsel, V., Rojas-Sutterlin, S., Tratwal, J., et al. (2019). The NAD-booster nicotinamide riboside potently stimulates hematopoiesis through increased mitochondrial clearance. Cell Stem Cell 24 (3), 405–418. e407. doi:10.1016/j.stem.2019.02.012
Virag, L., Salzman, A. L., and Szabo, C. (1998). Poly(ADP-ribose) synthetase activation mediates mitochondrial injury during oxidant-induced cell death. J. Immunol. 161 (7), 3753–3759.
Waldén, T. B., Hansen, I. R., Timmons, J. A., Cannon, B., and Nedergaard, J. (2012). Recruited vs. nonrecruited molecular signatures of brown, “brite, ” and white adipose tissues. Am. J. Physiol. Endocrinol. Metab. 302 (1), E19–E31. doi:10.1152/ajpendo.00249.2011
Wang, H., Kuusela, S., Rinnankoski-Tuikka, R., Dumont, V., Bouslama, R., Ramadan, U. A., et al. (2020). Tankyrase inhibition ameliorates lipid disorder via suppression of PGC-1α PARylation in db/db mice. Int. J. Obes. 44 (8), 1691–1702. doi:10.1038/s41366-020-0573-z
Wang, T., Si, Y., Shirihai, O. S., Si, H., Schultz, V., Corkey, R. F., et al. (2010). Respiration in adipocytes is inhibited by reactive oxygen species. Obesity 18 (8), 1493–1502. doi:10.1038/oby.2009.456
Wu, J., Bostrom, P., Sparks, L. M., Ye, L., Choi, J. H., Giang, A. H., et al. (2012). Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 150 (2), 366–376. doi:10.1016/j.cell.2012.05.016
Wu, J., Singh, K., Lin, A., Meadows, A. M., Wu, K., Shing, V., et al. (2022). Boosting NAD+ blunts TLR4-induced type I IFN in control and systemic lupus erythematosus monocytes. J. Clin. Invest. 132 (5), e139828. doi:10.1172/jci139828
Wu, L., Zhang, L., Li, B., Jiang, H., Duan, Y., Xie, Z., et al. (2018). AMP-activated protein kinase (AMPK) regulates energy metabolism through modulating thermogenesis in adipose tissue. Front. Physiol. 9, 122. doi:10.3389/fphys.2018.00122
Yamaguchi, S., Franczyk, M. P., Chondronikola, M., Qi, N., Gunawardana, S. C., Stromsdorfer, K. L., et al. (2019). Adipose tissue NAD(+) biosynthesis is required for regulating adaptive thermogenesis and whole-body energy homeostasis in mice. Proc. Natl. Acad. Sci. U. S. A. 116 (47), 23822–23828. doi:10.1073/pnas.1909917116
Yan, M., Audet-Walsh, E., Manteghi, S., Dufour, C. R., Walker, B., Baba, M., et al. (2016). Chronic AMPK activation via loss of FLCN induces functional beige adipose tissue through PGC-1α/ERRα. Genes. Dev. 30 (9), 1034–1046. doi:10.1101/gad.281410.116
Yeh, T. Y., Beiswenger, K. K., Li, P., Bolin, K. E., Lee, R. M., Tsao, T. S., et al. (2009). Hypermetabolism, hyperphagia, and reduced adiposity in tankyrase-deficient mice. Diabetes 11, 2476–2485. doi:10.2337/db08-1781
Zhu, Q., Ghoshal, S., Rodrigues, A., Gao, S., Asterian, A., Kamenecka, T. M., et al. (2016). Adipocyte-specific deletion of Ip6k1 reduces diet-induced obesity by enhancing AMPK-mediated thermogenesis. J. Clin. Invest. 126 (11), 4273–4288. doi:10.1172/JCI85510
Keywords: beige adipocyte, mitochondrial oxidation, nicotinamide riboside, uncoupled respiration, adipocyte differentiation
Citation: Nagy L, Rauch B, Szerafin T, Uray K, Tóth A and Bai P (2022) Nicotinamide-riboside shifts the differentiation of human primary white adipocytes to beige adipocytes impacting substrate preference and uncoupling respiration through SIRT1 activation and mitochondria-derived reactive species production. Front. Cell Dev. Biol. 10:979330. doi: 10.3389/fcell.2022.979330
Received: 27 June 2022; Accepted: 28 July 2022;
Published: 22 August 2022.
Edited by:
Endre Károly Kristóf, University of Debrecen, HungaryReviewed by:
Monica Colitti, University of Udine, ItalyTibor Pankotai, University of Szeged, Hungary
Copyright © 2022 Nagy, Rauch, Szerafin, Uray, Tóth and Bai. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Péter Bai, baip@med.unideb.hu